UBS AM’s Shattuck Labs STTK Stock Holding History

UBS AM’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,628	Closed	-$53.8K	–	2768
2022 Q1	$53.8K	Hold	12,628	–	–	﹤0.01%	2762
2021 Q4	$107K	Buy	+12,628	New	+$174K	﹤0.01%	2815

Other funds holding STTK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CEI

Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

CCG

Cloverfields Capital Group Minneapolis, Minnesota $309M AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS AM's STTK Position: Q2 2022 in Review

UBS AM sold out of Shattuck Labs (STTK) in Q2 2022, closing a stake of 12,628 shares — an estimated $53.8K sold.

UBS AM first reported a position in STTK in Q4 2021 and held it in 2 quarters. The position peaked at $107K in Q4 2021. 71 funds tracked by Wall St. Rank hold STTK as of Q2 2022.

UBS AM reported no remaining Shattuck Labs position as of Q2 2022 after selling out during the quarter.
UBS AM sold 12,628 Shattuck Labs shares in Q2 2022, an estimated $53.8K.
UBS AM first reported a position in Shattuck Labs in Q4 2021 and held it in 2 quarters.
UBS AM's Shattuck Labs position peaked at $107K in Q4 2021.
71 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.